DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer

Study ID
NCT00024375

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DHA-paclitaxel in treating patients who have metastatic pancreatic cancer.

More informations

Trial Starting Date

Jun 30,2001

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit